We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Northrim BanCorp
NRIM
$587M
| $604K | ﹤0.01% |
96,116
-3,916
| -4% | -$22.7K |
|
|
CDTX
2827
DELISTED
Cidara Therapeutics
CDTX
| $602K | ﹤0.01% |
+8,145
| New | +$528K |
|
|
CWBC
2828
Community West Bancshares
CWBC
$684M
| $602K | ﹤0.01% |
39,151
-2,020
| -5% | -$28K |
|
2829
Infosys
INFY
$50.7B
| $599K | ﹤0.01% |
62,009
-2,247
| -3% | -$20.1K |
|
2830
Tilly's
TLYS
$128M
| $599K | ﹤0.01% |
105,653
-52,838
| -33% | -$272K |
|
2831
Nathan's Famous
NATH
$402M
| $597K | ﹤0.01% |
10,621
-1,101
| -9% | -$62.5K |
|
2832
Clearfield
CLFD
$374M
| $596K | ﹤0.01% |
42,730
+5,467
| +15% | +$70.8K |
|
2833
Tiptree Inc
TIPT
$675M
| $589K | ﹤0.01% |
91,266
-4,199
| -4% | -$24.7K |
|
|
ORTX
2834
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $587K | ﹤0.01% |
9,788
-2,101
| -18% | -$192K |
|
|
LOVE
2835
LoveSac
LOVE
$261M
| $584K | ﹤0.01% |
22,277
-8,681
| -28% | -$132K |
|
|
OSG
2836
DELISTED
Overseas Shipholding Group Inc.
OSG
| $584K | ﹤0.01% |
313,929
+56,231
| +22% | +$125K |
|
|
PFBI
2837
DELISTED
Premier Financial Bancorp
PFBI
| $584K | ﹤0.01% |
45,538
-4,340
| -9% | -$53.8K |
|
2838
Lakeland Industries
LAKE
$119M
| $581K | ﹤0.01% |
+25,902
| New | +$424K |
|
2839
Century Casinos
CNTY
$34M
| $579K | ﹤0.01% |
139,531
+3,317
| +2% | +$13.9K |
|
|
SFE
2840
DELISTED
Safeguard Scientifics, Inc.
SFE
| $579K | ﹤0.01% |
82,661
-9,500
| -10% | -$60.1K |
|
2841
Distribution Solutions Group
DSGR
$1.61B
| $578K | ﹤0.01% |
35,884
-27,802
| -44% | -$440K |
|
|
AAIC
2842
DELISTED
Arlington Asset Investment Corp.
AAIC
| $578K | ﹤0.01% |
194,826
-347,434
| -64% | -$930K |
|
|
BMY.RT
2843
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $577K | ﹤0.01% |
161,336
| – | – |
|
|
CBIO
2844
Crescent Biopharma
CBIO
$626M
| $575K | ﹤0.01% |
1,527
+200
| +15% | +$56.6K |
|
|
GCAP
2845
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $575K | ﹤0.01% |
95,507
+149
| +0.2% | +$917 |
|
2846
Boston Omaha
BOC
$436M
| $574K | ﹤0.01% |
35,855
+6,082
| +20% | +$102K |
|
|
APTX
2847
DELISTED
Aptinyx Inc. Common Stock
APTX
| $574K | ﹤0.01% |
+137,678
| New | +$466K |
|
2848
Orrstown Financial Services
ORRF
$838M
| $564K | ﹤0.01% |
38,199
+3,352
| +10% | +$44.8K |
|
|
PWOD
2849
DELISTED
Penns Woods Bancorp
PWOD
| $564K | ﹤0.01% |
24,843
-105
| -0.4% | -$2.34K |
|
|
TELL
2850
DELISTED
Tellurian Inc.
TELL
| $563K | ﹤0.01% |
489,711
-255,059
| -34% | -$323K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.